Skip to main content
. 2024 Sep 19;13(9):513–524. doi: 10.1302/2046-3758.139.BJR-2024-0109

Fig. 6.

Fig. 6

Findings from surveys when respondents were asked about how acceptable they thought different drug administration routes are. a) Healthcare professionals, clinicians and/or researchers (HCP/R) answers from Survey 1. b) People with joint damage caused by knee injury and/or osteoarthritis (PJD) answers from Survey 2. Multiple answers could be selected; 14 HCP/R respondents gave a total of 41 responses, and 30 PJD respondents gave a total of 136 responses.